Frontlight ResearchEarly access
Trial site
Hausaerztlich-Kardiologisches MVZ Am Felsenkeller GmbH
- 6running trials
- 5closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Heart failure4 trials
- Obesity3 trials
- Atrial fibrillation1 trial
- Chronic kidney disease1 trial
- Coronary artery disease1 trial
- Hypertrophic cardiomyopathy1 trial
- Stroke1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 38 trials
- Phase 22 trials
- Phase 2/31 trial
- Status
- Completed5 trials
- Active, not recruiting3 trials
- Recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Novo Nordisk A/S2 trials
- Amgen1 trial
- Amgen Inc.1 trial
- AstraZeneca1 trial
- Bayer1 trial
- and 5 more
Running trials
Not yet recruiting
Efficacy And Safety of Olatorepatide in Adults With Overweight or Obesity Without Diabetes
Not yet recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity2 recruiting
- Heart failure1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 19 Nov 2026